Dynamic Wealth Report | May 14 2014
Free, No Strings Attached Report: How to Spot Penny Stock Scams
After you read our brand new FREE report, you'll never again trade penny stocks the way you used to. Learn how crooked promoters use every trick in the book to try to separate you from your money. Our just-released report will give you the information you need to outsmart the scammers.
Make 2014 the year in which you finally get the edge. And learn how you can become one of only 1,000 elite members that are participating in our cutting-edge trading service. To make things even better, we are slashing the cost of the service to the lowest price ever.
Get your FREE report HERE.
Three Hot Penny Stocks
By Robert Morris, Penny Stock Research
 It's been a difficult couple of months for small-caps and penny stocks. Since hitting an all-time record high of 1,212.80 on March 4th, the Russell 2000 Index has lost nearly 100 points or 8.2%.
And just last Friday, the small-cap index hit a low of 1,091.40, which represented a 10% drop from the early March high.
With that said, there are a number of penny stocks that continue to perform well despite the overall weakness in small company stocks. In fact, here are three penny stocks that skyrocketed last week...
Hyperdynamics (NYSE: HDY)
Shares of this tiny oil and gas exploration company jumped last week!
HDY started the week strong by tripling in value on Monday, May 5th. But the stock couldn't hang on to its stunning gains. By the close of trading on Friday, HDY had dropped from Monday's close of $4.46 to just $2.79.
With that said, HDY did manage to register an eye-popping 87% rise for the week.
Hyperdynamics is engaged in the acquisition, exploration and development of oil and gas properties in the Republic of Guinea, which is located in Northwest Africa. The company owns a 37% working interest in a concession that covers an area of approximately 9,650 square miles in offshore Guinea.
Why did the stock take off?
The company's drilling partner, Tullow Oil, announced it has lifted its force majeure on the Guinea offshore exploration block.
Tullow imposed the force majeure on March 12th after the Justice Department and the SEC initiated an investigation into Hyperdynamics. The regulators are scrutinizing the company's activities in obtaining and retaining its rights to the Guinea concession.
HDY plunged 58% the day the news came out.
While there has been no word on the outcome of the investigation yet, it appears investors are viewing Tullow's actions as a positive sign. Tullow had previously stated it imposed the force majeure because "it cannot proceed with activities on the license until these issues are resolved."
By lifting the force majeure, Tullow appears to be indicating that the regulatory investigation of Hyperdynamics has been resolved to its satisfaction. If so, then perhaps last week's surge is the beginning of a larger rally for HDY.
Shares of HDY are up 3.2% so far this week at $2.88.
RadNet (NASDAQ: RDNT)
RadNet is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of 250 fully-owned and operated outpatient imaging centers. The company's core markets include California, Maryland, Delaware, Rhode Island, New Jersey, and New York.
On Friday, the company reported a narrower first quarter loss than analysts' were expecting.
While revenue declined 2.4% year-over-year to $168.9 million, net loss remained flat at $0.03 per share. The bottom-line number impressed investors as analysts' had been expecting a much wider loss of $0.06 per share.
It also didn't hurt that management suggested the numbers would have been even better had it not been for bad weather on the East Coast during the quarter.
What's more, the company raised its full-year EBITDA guidance by $2 million to a range of $112 to $122 million. The original guidance had forecasted EBITDA of $110 to $120 million.
Thanks to the bullish news... RDNT finished the week with a bang!
As you can see, the shares jumped nearly 22% on Friday and set a new 52-week high of $6.80 in the process. The rally capped off a strong week for the stock which finished with a 31% gain.
While RadNet has shed about 10 cents so far this week, it is still up by a whopping 280% year-to-date.
And, it doesn't appear that RadNet has much more upside in the near-term. At a current price of $6.38, the stock is trading just off the analysts' mean price target of $6.50 per share.
Chelsea Therapeutics International (NASDAQ: CHTP)
CHTP surged on big news last week...
The small biotech's shares jumped $1.58 on Thursday for a one-day gain of 32%. And the stock finished the week at $6.57 for a gain of 28% for the week.
What spurred the sudden rise in CHTP?
Early Thursday morning, management announced that Chelsea will be acquired by privately-owned, Dutch pharmaceutical company, H. Lundbeck A/S. The deal values Chelsea at approximately $658 million.
Lundbeck is buying Chelsea to get its hands on Northera, Chelsea's FDA-approved drug for symptomatic neurogenic orthostatic hypotension.
According to a joint press release, Lundbeck will offer Chelsea shareholders $6.44 per share in cash and up to $1.50 per share in contingent value rights. The total potential consideration of up to $7.94 per share represents a 59% premium over Chelsea's closing price of $5.00 on May 7th.
Chelsea's board of directors has unanimously approved the transaction. And the deal is expected to close in the third quarter.
It's not clear at this time just how much the contingent value rights will ultimately be worth. Their value depends on future net sales of Northera, which the companies expect to launch in the second half of 2014.
With CHTP currently trading at $6.59, there doesn't seem to be much upside remaining in the shares. We suggest you look for better opportunities in the penny stock space.
Profitably Yours,
Robert Morris
| | | | | | Copyright 2014 Hyperion Financial Group, LLC. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This email may only be used pursuant to the subscription agreement controlling use of the Dynamic Wealth Report website and any reproduction, copying, or redistribution of this email or its contents, in whole or in part, is strictly prohibited without the express written permission of Hyperion Financial Group, LLC.
LEGAL DISCLAIMER: Neither Hyperion Financial Group LLC nor any of it's employees, contractors or officers are registered investment advisors or a Broker/Dealer. As such, Hyperion Financial Group, LLC does not offer or provide personalized investment advice. Although Hyperion Financial Group, LLC employees and contractors may answer general customer service questions, they are not licensed under securities laws to address your particular investment situation. Nothing in this report, nor any communication by our employees or contractors to you should be considered personalized investment advice.
Owners and writers may have positions in the securities that are discussed. However, no associated employees or contractors may intentionally engage in any transaction that directly or indirectly competes with the interests of our subscribers. We accept no compensation from any companies mentioned in our reports.
Past performance is no guarantee of future results. All information is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell any security. All opinions, analyses and information contained herein are based on sources believed to be reliable and written in good faith, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. Investments recommended in this publication should only be made after consulting with your financial advisor. | |
No comments:
Post a Comment
Keep a civil tongue.